Key Segments
By Technology:
-
PCR (Polymerase Chain Reaction)
-
Sequencing
-
Microarray
By Application:
-
Oncology
-
Cardiology
-
Neurology
By End User:
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Pharmaceutical & Biotechnology Companies
By Drug Type / Treatment Focus:
-
Targeted Therapy Drugs
-
Immunotherapy Drugs
-
Cardiovascular Drugs
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Pharmacogenomics Market is expected to grow at a CAGR of 9.50% during 2026–2035.
The market was valued at USD 8.07 Billion in 2025 and is projected to reach USD 19.99 Billion by 2035.
The key drivers of the Pharmacogenomics Market include rising adoption of personalized medicine, advancements in genomic technologies, increasing chronic disease prevalence, growing biopharmaceutical R&D, and integration of AI and bioinformatics for precision therapies.
The Oncology application segment dominated during the projected period.
North America dominated the Pharmacogenomics Market in 2025.